Capecitabine and cisplatin as a second-line chemotherapy for patients with advanced biliary tract cancer

被引：0
|
作者：
Shin, Kabsoo
Lee, In Seok
Hong, Tae Ho
Kim, Joori
Lee, Myung Ah
机构：
[1] Catholic Univ Korea, Seoul St Marys Hosp, Seoul, South Korea
[2] Catholic Univ Korea, Seoul, South Korea
[3] Seoul St Marys Hosp, Dept Surg, Seoul, South Korea
[4] Seoul St Marys Hosp, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
543
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Combination therapy with capecitabine and cisplatin as second-line chemotherapy for advanced biliary tract cancer
    Jung, Jang Han
    Chung, Moon Jae
    Bang, Seungmin
    Park, Seung Woo
    Song, Si Young
    Park, Jeong Youp
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 210 - 210
  • [2] Combination Therapy with Capecitabine and Cisplatin as Second-Line Chemotherapy for Advanced Biliary Tract Cancer
    Jung, Jang Han
    Lee, Hee Seung
    Jo, Jung Hyun
    Cho, In Rae
    Chung, Moon Jae
    Bang, Seungmin
    Park, Seung Woo
    Song, Si Young
    Park, Jeong Youp
    CHEMOTHERAPY, 2017, 62 (06) : 361 - 366
  • [3] Second-line chemotherapy in patients with advanced biliary tract cancer
    Takahara, Naminatsu
    Nakai, Yousuke
    Isayama, Hiroyuki
    Sasaki, Takashi
    Ishigaki, Kazunaga
    Saito, Kei
    Mizuno, Suguru
    Kogure, Hirofumi
    Tada, Minoru
    Koike, Kazuhiko
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [4] Second-line FOLFOX chemotherapy for advanced biliary tract cancer
    Wei, Fangqiang
    LANCET ONCOLOGY, 2021, 22 (07): : E284 - E284
  • [5] Benefit of second-line chemotherapy for advanced biliary tract cancer.
    Moik, Florian
    Riedl, Jakob M.
    Winder, Thomas
    Bezan, Angelika
    Rossmann, Christopher
    Szkandera, Joanna
    Kasparek, Anne-Katrin
    Schaberl-Moser, Renate
    Pichler, Martin
    Stoger, Herbert
    Stotz, Michael
    Gerger, Armin
    Posch, Florian
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] SECOND-LINE CHEMOTHERAPY IN ADVANCED BILIARY TRACT CANCER: A RETROSPECTIVE SERIES
    Brungs, Daniel
    Aghmesheh, Morteza
    Sjoquist, Katrin
    Goldstein, David
    Asia-Pacific Journal of Clinical Oncology, 2015, 11 : 168 - 168
  • [7] Second-line chemotherapy in patients with biliary tract cancer.
    Brandi, G.
    Di Girolamo, S.
    de Rosa, F.
    Corbelli, J.
    Agostini, V.
    Garajova, I.
    Longobardi, C.
    Paragona, M.
    Ercolani, G.
    Pinna, A. D.
    Biasco, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [8] Feasibility and potential benefits of second-line chemotherapy in patients with advanced biliary tract cancer
    Walter, Thomas
    Horgan, Anne M.
    McKeever, Elizabeth
    Min, Trisha
    McNamara, Mairead
    Hedley, David W.
    Serra, Stefano
    Krzyzanowska, Monika K.
    Chen, Eric Xueyu
    Mackay, Helen
    Feld, Ronald
    Moore, Malcolm J.
    Knox, Jennifer J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [9] SECOND-LINE CHEMOTHERAPY WITH S-1 AFTER CISPLATIN AND GEMCITABINE FAILURE IN PATIENTS WITH ADVANCED BILIARY TRACT CANCER
    Ueda, Shinya
    Kawakami, Hisato
    Okamoto, Wataru
    Nishina, Shinichi
    Kudo, Toshihiro
    Makimura, Chihiro
    Kiyota, Hidemi
    Tanaka, Kaoru
    Kaneda, Hiroyasu
    Fujisaka, Yasuhito
    Miyazaki, Masaki
    Turutani, Junji
    Okamoto, Isamu
    Kurata, Takayasu
    Nakagawa, Kazuhiko
    ANNALS OF ONCOLOGY, 2012, 23 : 65 - 65
  • [10] Prognostic factor analysis of second-line chemotherapy in advanced biliary tract cancer
    Lee, Sang-Cheol
    Kim, Kyoungha
    Kim, Hanjo
    Kim, Hyun Jung
    Kim, Se Hyung
    Bae, Sang-Byung
    Kim, Chan Kyu
    Lee, Namsu
    Lee, Kyu Taek
    Park, Sung Kyu
    Won, Jong-Ho
    Yun, Jina
    Hong, Dae Sik
    Park, Hee Sook
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345